Cyclo (-RGDfK)
Cyclo (-RGDfK) is a highly potent and selective αvβ3 integrin inhibitor (IC50 = 0.94 nM) . It is widely used in cancer research to study tumor angiogenesis and metastasis through its targeted binding to αvβ3 on endothelial and cancer cells in both in vitro and in vivo models.
Product Specifications
Product Name Alternative
-RGDfK, αvβ3 integrin, αVβ3 integrin, tumoral cell, cancer, Cyclo (RGDfK), Cyclo (-RGDfK), Cyclo (RGDfK), Cyclo, Cyclo (-RGDfK), Inhibitor, Integrin, Microvasculature, inhibit, ligand
Field of Research
Signal Transduction
Purity
95.29% (May vary between batches)
Solubility
DMSO:100 mg/mL (165.65 mM) ; Ethanol:84 mg/mL (139.15 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (6.63 mM) ; H2O:80 mg/mL (132.52 mM)
Molecular Weight
603.67
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
